Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-22-289924
Filing Date
2022-11-21
Accepted
2022-11-21 16:07:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d398425dsc13d.htm SC 13D 46564
2 EX-99.A d398425dex99a.htm EX-99.A 598160
  Complete submission text file 0001193125-22-289924.txt   646108
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Subject) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91894 | Film No.: 221405818
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address
Bell Robert G. (Filed by) CIK: 0001955394 (see all company filings)

Type: SC 13D